Jordan: pharmaceuticals cluster growth & medical services cluster report
Jordan government experts expect that its pharmaceutical industry will quadruple over the next 8 years and the U.S. Agency for International Development reports on Jordan's Medical Services Cluster.
Jordan Expects $1 billion in Pharmaceuticals by 2010
Jordan's dedication to developing a strong cluster driven policy to develop its pharmaceutical industry is beginning to pay dividends and government experts expect that it will quadruple over the next years reaching one billion by 2010.
The core of Jordan's cluster consists of: 16 Pharmaceutical companies; 8 pharmaceutical colleges, and a bioequivalence research center. One of the outcomes of the report undertaken by AMIR (see below) has been that nations tend to succeed not in isolated industries, but in clusters of industries connected through vertical and horizontal linkages
Jordan's Medical Services Cluster
The U.S. Agency for International Development recently released its AMIR (Achievements of Market-Friendly Initiatives Results Program) report on Jordan's Medical Services Cluster. The report reviews Jordan's medical industry, its competitive advantage within the region, and opportunities for the medical tourism cluster.
Anderson Consulting estimated, that in the past four years, Jordan hosted between 27,000 and 32,000 patients annually, with average expenditures per patient totaling USD 5,500.
To read the complete report see: http://www.amir-jordan.org/pdf/del2/512%20Final%20Report.pdf
Send article
List of comments
There are no comments.